![](https://www.diabetesnews.com/wp-content/uploads/2013/06/20100824_-medtronic-headquarters_33-150x150.jpg)
Medtronic has received two new European approvals for their diabetes monitoring and management devices: for expanded functionality of the InPen, a connected insulin pen designed for users requiring multiple daily injections, and for the Guardian 4 sensor, which can be used either as a standalone continuous glucose monitor or in tandem with the InPen or Medtronic’s MiniMed 780G insulin pump. Read more